Budesonide and formoterol differentially modulate the expression of C/EBP-alpha and calreticulin in airway smooth muscle (ASM) cells

P. Borger, M. Tamm, M. Roth (Basel, Switzerland; Sydney, Australia)

Source: Annual Congress 2006 - Cellular mechanisms of airway disease
Session: Cellular mechanisms of airway disease
Session type: Oral Presentation
Number: 4355
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Borger, M. Tamm, M. Roth (Basel, Switzerland; Sydney, Australia). Budesonide and formoterol differentially modulate the expression of C/EBP-alpha and calreticulin in airway smooth muscle (ASM) cells. Eur Respir J 2006; 28: Suppl. 50, 4355

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Eosinophils promote airway smooth muscle cells contractility and a-actin gene expression in asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Bosentan blocks TNFα-induced GM-CSF expression in human airway smooth muscle cells
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

Formoterol reduces asthmatic airway smooth muscle cell proliferation through p27 (Kip) which is supported by steroids
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012


The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC)
Source: Annual Congress 2011 - Understanding disease and drug mechanisms
Year: 2011



Compound A (CpdA) suppressed production of corticosteroid-resistant chemokines via GR-independent mechanisms in airway smooth muscle (ASM) cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

A comparison of beta2-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006

Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011


Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002

IL-1β-induced MCP-1 production in human airway smooth muscle cells, modulation by dexamethasone, rolipram, and salbutamol
Source: Eur Respir J 2001; 18: Suppl. 33, 353s
Year: 2001

Upregulation of airway smooth muscle (ASM) cell apoptosis may limit ASM growth during airway remodeling in experimental asthma
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008

Airway hyperresponsiveness development is related to airway smooth muscle cytosolic β1 integrin subunit expressing cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010

Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009

Transcriptional regulation of CXCL8 hypersecretion in asthmatic airway smooth muscle cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009


Differential CCAAT/enhancer binding protein (C/EBP) isoforms expression in human bronchial smooth muscle cells of asthmatic and COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 695s
Year: 2004

IL33 and TNFalpha synergistically enhance store operated Ca2+ entry in cultured human airway smooth muscle cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013


LSC Abstract – Eosinophils enhance WNT-5a and TGF-β1 genes expression in airway smooth muscle cells and promote their proliferation in asthma
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016

CRE, but not AP-1, NF-κB, or C/EBP, mediates β-agonist-induced IL-6 gene expression induced in human airway smooth muscle (HASM) cells
Source: Eur Respir J 2001; 18: Suppl. 33, 407s
Year: 2001

Long-acting beta2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013